Brief: Iveric Bio Reports Second Quarter 2021 Operational Highlights And Financial Results
04/08/2021 12:20
Aug 4 (Reuters) - Iveric Bio Inc ISEE.O :
* IVERIC BIO REPORTS SECOND QUARTER 2021 OPERATIONAL
HIGHLIGHTS
AND FINANCIAL RESULTS
* Q2 LOSS PER SHARE $0.32
* ESTIMATES CASH BALANCE, AVAILABLE FOR SALE SECURITIES WILL
BE
SUFFICIENT TO FUND PLANNED CAPEX, EXPENSES THROUGH AT LEAST MID-
2024
Source text for Eikon: ID:nBw82pG6Pa
Further company coverage: ISEE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on IVERIC bio
See all newsBrief: Astellas Pharma Inc - Astellas Completes Acquisition Of Iveric Bio
Analysis: Amgen's antitrust woes spur wider pharmaceutical deal fears
Iveric Bio Inc Reports Results For The Quarter Ended In March: Earnings Summary
The end of cheap credit could hurry Japanese M&A
U.S. STOCKS ON THE MOVE-US banks, Biomea Fusion, Tutor Perini